Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
4.670
-0.090 (-1.89%)
At close: Aug 10, 2026, 4:00 PM EDT
4.580
-0.090 (-1.93%)
After-hours: Aug 10, 2026, 7:34 PM EDT

Treace Medical Concepts Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3031564647871,2791,010
Market Cap Growth
-11.95%-66.28%-41.07%-38.44%26.63%-
Enterprise Value
326.47177.66457.53732.991,266933.47
Last Close Price
4.672.457.4412.7522.9918.64
PS Ratio
1.480.742.224.219.0210.70
PB Ratio
4.481.794.115.7121.1310.85
P/TBV Ratio
6.222.305.026.6821.009.70
EV/Sales Ratio
1.590.842.193.928.929.89
Debt / Equity Ratio
1.020.800.610.501.130.32
Net Debt / Equity Ratio
0.350.24-0.06-0.39-0.21-0.82
Net Debt / EBITDA Ratio
-0.52-0.490.141.180.404.83
Net Debt / FCF Ratio
-0.94-0.720.131.180.293.84
Asset Turnover
1.101.040.890.910.951.03
Inventory Turnover
1.121.141.201.451.711.84
Quick Ratio
1.792.953.343.583.656.83
Current Ratio
2.904.314.624.404.417.58
Return on Equity (ROE)
-76.76%-58.94%-44.45%-49.91%-55.75%-43.80%
Return on Assets (ROA)
-28.91%-26.57%-23.75%-25.03%-23.24%-18.08%
Return on Invested Capital (ROIC)
-52.28%-49.67%-58.57%-78.39%-108.37%-107.57%
Return on Capital Employed (ROCE)
-35.87%-31.66%-28.63%-30.64%-27.72%-21.61%
Buyback Yield / Dilution
-2.71%-1.86%-2.07%-10.09%-14.17%-30.61%
Total Shareholder Return
-2.71%-1.86%-2.07%-10.09%-14.17%-30.61%
SEC Filings: 10-K · 10-Q